UNSPSC 51283947: Sulfadiazine sodium

This classification denotes a sulfonamide anti-infective agent with the molecular formula C10H9N4O2S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 84CS1P306F, chemically known as trisulfapyrimidine, oral suspension but more generally known as sulfadiazine sodium, which bears US NIH Compound Identifier 5215. European Medicines Agency schedules Sulfadiazine sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10696MIG.

UNSPSC 51283947 Sulfadiazine sodium is a Commodity code that represents a single pharmaceutical product — the sodium salt form of sulfadiazine antibiotic — yet the recent state and local opportunities tagged under this code show little alignment with that specific drug. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets; Seminole County, Florida issued an IFB on June 30, 2026, for Naloxone and Safe Drug Deactivation Systems. Neither opportunity directly involves sulfadiazine sodium. The mismatch suggests the code may have been applied broadly to pharmaceutical procurement activities rather than reserved for sulfadiazine sodium specifically. When state and local procurement offices actually solicit sulfadiazine sodium, they are likely purchasing antibiotic inventory for public health stockpiling, emergency preparedness, or clinical supply — typically through state health departments, county health systems, or hospital networks — but the recent-opportunities block does not capture activity in that category.

The geographic spread and issuing-body mix evident in the two records reflect state health agencies and county health authorities across different regions (Illinois and Florida), though the limited sample and the mismatch between code and actual procurement make it difficult to characterize concentration or to project future sulfadiazine sodium activity. The Illinois award totaled $2,999,999.11 over the life of the contract with a 12-month initial term and two renewal options; Seminole County's procurement called for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries. If your firm pursues sulfadiazine sodium supply to state or local governments, monitor state health department procurement offices and cooperative purchasing vehicles — but do not rely on this code's recent-opportunities record as a leading indicator of current sulfadiazine sodium demand.